Pre-Market Stock News (November 20, 2007)
Biogen Idec (BIIB) announced an alliance with Neurimmune Therapeutics to develop treatments for Alzheimer’s Disease.BJ’s Wholesale (BJ) $0.35 EPS vs $0.33 est.Blue Coat Systems (BCSI) $0.30 EPS vs $0.24 est.; sees next quarter $0.31 to $0.35 EPS vs. $0.26 est.DR…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Biogen Idec (BIIB) announced an alliance with Neurimmune Therapeutics to develop treatments for Alzheimer’s Disease.
BJ’s Wholesale (BJ) $0.35 EPS vs $0.33 est.
Blue Coat Systems (BCSI) $0.30 EPS vs $0.24 est.; sees next quarter $0.31 to $0.35 EPS vs. $0.26 est.
DR Horton (DHI) trading up 4% after posting narrower than expected losses at -$0.16 EPS vs -$0.60 EPS; sales down 35%.
Freddie Mac (FRE) posted a $3.29 EPS loss; engaged Goldman Sachs and Lehman to advise on near term financial concerns for capital raising after discussing lower mortgage loan values in its portfolio; apparently considering dividend cut; shares down 6% or more.
Fannie Mae (FNM) trading down 6% with Freddie Mac.
H-P (HPQ) beat earnings and slightly raised guidance; announced an $8 Billion share buyback
JW Nordstom (JWN) beat earnings and raised guidance; stock traded up 10%.
McClatchy Co (MNI) reports that both consolidated advertising and total revenues in October 2007 decreased 9.9%.
New York & Co. (NWY) $0.09 EPS vs $0.07 est; sees next quarter $0.23 to $0.32 EPS vs. $0.30 est.
Retalix (RTLX) $0.23 EPS vs $0.18 est.
Shoe Carnival (SCVL) $0.33 EPS vs $0.32 est.
Van Der Moolen (VDM) announced resignation of COO.
Zale (ZLC) -$0.54 EPS vs -$0.60 est.; sees next quarter $1.87-1.92 EPS vs. $1.80 est.; sees 2008 under plan.
Contact [email protected] for any questions or corrections.
